Long-term response rates to infliximab therapy for Crohn’s disease in an outpatient cohort
AUTOR(ES)
Teshima, Christopher W
FONTE
Pulsus Group Inc
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2706747Documentos Relacionados
- Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease
- Metastatic Crohn’s disease despite infliximab therapy
- Influence of dystonia on the response to long-term L-dopa therapy in Parkinson's disease
- Long-Term Oxygen Therapy
- Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment